Aggregation of microtubule-associated protein tau is the hallmark of tauopathies, including Alzheimer's disease. Eftekharzadeh et al. (2018) demonstrate that pathogenic tau alters nucleocytoplasmic transport by interacting with components of the nuclear pore complex, revealing a perturbation shared by multiple neurodegenerative diseases.
Insoluble protein aggregates are a common feature of many neurodegenerative diseases. For example, a-synuclein forms aggregates in Parkinson's disease, microtubule-associated protein tau (tau) forms aggregates in Alzheimer's Disease (AD) and other tauopathies, and TDP-43 is found in cytoplasmic aggregates in amyotrophic lateral sclerosis (ALS) and some forms of frontotemporal lobar degeneration (FTLD). Unanswered questions about protein aggregates include whether the toxic protein species is the large aggregate or a smaller oligomer and how such protein oligomers or aggregates affect cell physiology and lead to neuronal death. A striking commonality is that a number of different protein aggregates, or cytoplasmic assemblies, have now been shown to alter nucleocytoplasmic transport (NCT), which can have toxic consequences.
NCT refers to the import and export of macromolecules from the nucleus. Nuclear-cytoplasmic transport is primarily regulated by the nuclear pore complex (NPC), a structure embedded in the nuclear membrane made up of multiple copies of 30 distinct proteins referred to as nucleoporins (Nups). NCT can be active (requiring energy) or passive (dependent on diffusion). Active transport is dependent on Ran-GTP, a nuclear GTP-binding protein. During nuclear import, importin proteins bind cargo in the cytoplasm and pass through the NPC. The importin then interacts with Ran-GTP in the nucleus, which causes a conformational change and release of cargo. During export, exportins in the nucleus bind to both cargo and Ran-GTP and then pass through the NPC. In the cytoplasm, cargo is released when Ran GTPase activating protein 1 (RanGAP1; located on the cytoplasmic face of the NPC) catalyzes the hydrolysis of Ran-GTP to Ran-GDP. Ran-GDP then recycles back into the nucleus, where it exchanges its GDP for GTP to continue the cycle. Disruptions to RanGAP1 or to the ratio of nuclear to cytoplasmic Ran can alter the rate and direction of active transport.
Perturbations in NCT have been observed in several conditions in which protein aggregates or large assemblies form (Figure 1 ). For example, in Huntington's disease (HD), aggregates of the polyQ expanded huntingtin protein (HTT) lead to mis-localization of at least Nup62, Nup88, and RanGAP1; a decrease in nuclear Ran protein; and a change in the localization of reporter proteins between the nucleus and cytosol (Grima et al., 2017) . Similarly, cytoplasmic aggregates of an aggregation-prone TDP-43 fragment or expression of artificial proteins rich in b-sheets that form cytoplasmic aggregates alter NCT, as assessed by mis-localization of importin a-1, importin a-3, and THOC2 (an mRNA transport protein) and by the change in localization of reporter proteins (Woerner et al., 2016) . The effect on NCT extends beyond aberrant protein aggregates, since even stress granules, which are large assemblies of untranslating mRNAs and proteins that normally form when translation initiation is inhibited, similarly alter NCT (Zhang et al., 2018) . Moreover, the expression of polypeptides consisting of repeats of GR and PR, which are produced from repeat expansion RNAs, can form protein aggregates and/or trigger stress-granule formation leading to perturbations of NCT (Zhang et al., 2015 , Zhang et al., 2018 .
In this issue of Neuron, Eftekharzadeh et al. (2018) investigate NCT disruptions in a group of neurodegenerative diseases known as tauopathies. Tauopathies are characterized by hyperphosphorylated peri-nuclear aggregates of tau and encompass AD, some forms of FTLD, and chronic traumatic encephalopathy. Using AD patient brains and a mouse model of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), they show that Nups with phenylalanine-glycine repeat domains (FG domains) mis-localize from the nuclear membrane and associate with cytoplasmic tau aggregates (using an antibody that recognizes FG domains in Nups; NPC [414] ). Further, they observe that nuclei isolated from AD brains show increased permeability to large fluorescently tagged dextrans in extracts, which demonstrates alterations in the NPC diffusion barrier or the nuclear membrane. They also show that AD patient brains have a decrease in the nuclear-tocytoplasmic ratio (N:C ratio) of Ran-GTP suggesting impairments in active transport. They verify that NCT is disrupted by showing that a fluorescent reporter (3xNLS-tagged tdTomato-NES), which typically accumulates in the nucleus, localizes to the cytoplasm when neurons are treated with AD-brain-derived tau. Thus, pathological tau, like other protein aggregates, leads to alterations in NCT.
An unresolved issue is the mechanism by which pathogenic tau leads to perturbations in NCT. Several observations lead Eftekharzadeh et al. (2018) to suggest that phosphorylated tau (p-tau) interacts directly with Nup98 and that this promotes tau fibrillization leading to NCT inhibition-either by clogging the NPC or by sequestering other Nups in the cytosol (Figure 1) . First, in cells with p-tau aggregates, Nup98 is mis-localized from the NPC to the cytosol and co-localizes with tau. Second, a purified N-terminal fragment of Nup98 directly interacts with phosphorylated, but not unphosphorylated, tau. Third, the C-terminal domain of Nup98 is capable of promoting tau fibrillization in vitro and is incorporated into the resulting aggregates, although this domain was not seen to interact with tau by biochemical assays. Consistent with Nup98 promoting the toxicity of pathogenic tau, shRNA knockdown of Nup98 in primary mouse cortical neurons partially rescued the defect in Ran localization in response to exogenous toxic tau. This suggests that the defect in NCT seen with pathological tau is not due to a loss of Nup98 function through sequestration; instead, Nup98 may promote the formation of tau aggregates that limit NPC function through either blocking the nuclear pore or sequestering other Nups.
Several other models have been proposed for how protein aggregates might affect NCT by sequestering or altering the function of components of NCT machinery (Figure 1 ). Artificial aggregateprone b-sheet proteins sequester nuclear transport factors such as importin a-1, importin a-3, and THOC2 into cytoplasmic aggregates. This is suggested to trap proteins and RNAs in the nucleus, leading to decreased cell viability (Woerner et al., 2016) . Similarly, in the brains of patients with HD, expansions of the HTT protein sequester Nup62 and RanGAP1 into nuclear aggregates, leading to NCT disruptions. Interestingly, this defect in NCT can be rescued by overexpression of Ran or RanGAP1 (Grima et al., 2017) . In ALS C9orf72 models expressing GR and PR dipeptide repeats that induce stress-granule formation, 14 different Nups were mis-localized to stress granules correlating with NCT disruptions. The defect in NCT in this case seems to be directly due to stress-granule formation, since decreasing stress-granule formation using pharmacologic or genetic manipulations rescued the NCT defects (Zhang et al., 2018 ). An alternative model has also been proposed wherein the repeat-expansion RNAs produced from a hexanucleotide repeat in the C9orf72 gene, which is the most common genetic cause of ALS, interacts directly with RanGap1 to disrupt NCT. This defect can be rescued in Drosophila using small molecules and antisense oligonucleotides targeting the hexanucleotide repeat RNAs (Zhang et al., 2015) .
A potential unifying theme of many of these models is that protein aggregates, or protein oligomers, may sequester Nups, or other components of the NCT machinery, in a non-functional manner, thus reducing their effective concentration at the pore. NCT, and particularly the NPC, might be particularly vulnerable to perturbations in its components for two reasons. First, Nups are among the longest-lived proteins and may accumulate damage over their lifetimes (Toyama et al., 2013) . Second, since the NPC is made up of many proteins, even a partial reduction in multiple required NPC components can have a multiplicative effect on the number of fully functional NPCs. For example, if 30% of three essential Nups are sequestered in the cytosol, then the probability of having a fully assembled NPC is 35% (0. 7 3 ). Interestingly-and consistent with the NPC being sensitive to the stoichiometry of its components-several NUP genes have phenotypes when haplodeficient (Moris et al., 2016) .
Two types of observations suggest that alterations in NCT can contribute to neurotoxicity. First, in the case of HTT aggregates, blocking nuclear export using KPT-350, an inhibitor of Exportin-1, restores NCT defects and reduces cell death in primary cortical neurons (Grima et al., 2017) . Similarly, a genetic screen for suppressors of dipeptide repeat polypeptides, which induce stress granules and trigger NCT defects (Zhang et al., 2018) , identified perturbations of NCT components that could rescue or enhance these phenotypes (Freibaum et al., 2015; Zhang et al., 2018) . Second, mutations in Nup62 result in the neurodegenerative disease of infantile bilateral striatal necrosis (Basel-Vanagaite et al., 2006) . Two key questions for future work are 1) whether common NCT pathways are disrupted by different protein aggregates and 2) whether any of the therapeutic interventions that can restore NCT in one case can reduce pathogenesis and/or disease progression across multiple neurodegenerative diseases. For example, protein aggregates could both sequester Nups on their own and trigger stress-granule formation, leading to further mis-localization of Nups. Since inhibition of stress-granule formation has been shown to rescue NCT defects in C9orf72 ALS models (Zhang et al., 2018) , it may also rescue NCT defects in response to tau or TDP-43 aggregates. Consistent with this idea, reducing the levels of the stress-granule assembly factor, TIA-1, decreases stress-granule formation and extends lifespan in a mouse model of tauopathy (Apicco et al., 2018) .
In any case, the observation of Eftekharzadeh et al. (2018) that NCT is disrupted in tauopathies highlights the similar effects of different protein aggregates and raises the possibility that there could be broadly applicable therapeutic strategies for neurodegenerative diseases that target NCT.
